Company / Depreciation & Amortization
QuidelOrtho Depreciation & Amortization History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$442.0M
FY2025
5-year range
$48.8M / $457.2M
FY2021-FY2025
Trend
-2.5%
vs FY2024
Sector context
#23 of 135
Health Care
What the data says
QuidelOrtho's depreciation & amortization of $442M is higher than 83% of companies in the Health Care sector (FY2025). Improved from $457M to $442M over the past 2 years.
Based on SEC 10-K filings.
$442M in FY2025 with a 5-year CAGR of +55.4%. Top quartile in the Health Care sector.
Improved from $457M to $442M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +15.9%
- 5-Year CAGR
- +55.4%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 135This company $442.0M Sector average $334.5M
▼
+32.2% above sector average
Key checks
Key Insights
- 5-year CAGR of +55.4%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 2.5% year-over-year.
- Ranks #23 out of 135 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $442.0M | -2.5% |
| FY2024 | $453.4M | -0.8% |
| FY2023 | $457.2M | +61.2% |
| FY2022 | $283.6M | +481.1% |
| FY2020 | $48.8M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026